The Importance of Biofilm Penetration: A Review of Telavancin Reprinted from January/February 2025 Joseph Reilly, PharmD Clinical Coordinator, Infectious Disease AtlantiCare Regional Medical Center Atlantic City, New Jersey Theresa Human, PharmD, PhD, FNCS Medical Science Liaison Cumberland Pharmaceuticals Nashville, Tennessee Background Telavancin, a semisynthetic lipoglycopeptide antibiotic, has emerged as a promising agent against gram-positive pathogens, particularly MRSA.1 Its dual
MARCH 4, 2025